Can Airline Stocks Take Off Again?
Airline stocks' long-term trend of outperformance looks threatened.
The Flaw in ACE Limited's $28.3 Billion Acquisition of Chubb Corp.
Property and casualty insurer ACE Ltd. picks up Chubb Corp. for $28.3 billion. Who's getting the better deal?
Celgene Corporation Pays Up For Juno Therapeutics Inc. -- The Market Says "Show Me"
Celgene pays a huge premium for a 10% stake in Juno Therapeutics as part of a wider deal.
Greece Stares at the Abyss: What It Means for U.S. Investors
The Greek crisis moves into high gear, but U.S. investors have little to fear.
The 3 Best Stocks to Invest in Telecommunications
The telecom market has something for every investor. Here are three great picks for dividend hunters, turnaround players, and low-risk value investors.
Biotech Stocks: 2 to Avoid, 1 to Buy
Arrowhead Research Corp. and Galena Biopharma are two speculative biotech stocks that investors may want to avoid, while top dog Celgene Corp. still looks like a great pick up. Here's why.
Is This The Key to The Bull Market's Next Leg?
Corporations have been instrumental in supporting the bull market, and M&A could be the next driver.
Stock Watch: 1 Big Reason to Track TransUnion's IPO
Credit reporting agency TransUnion has a highly valuable asset.
What Does Netflix Inc's 7-for-1 Stock Split Really Mean?
Netflix announced a stock split, to no one's surprise. Shares jumped on the news anyhow. Here's what the split really means for Netflix investors.
Netflix's 7-for-1 Stock Split Is Bad News for Genuine Investors
Netflix will split its shares seven-for-one next month. The stock market likes the news, but investors shouldn't.